Will Commission heed COCIR’s Comprehensive And Sometimes Radical Solutions To MDR Delays?
Executive Summary
Industry’s timely compliance with the EU’s new medtech regulations is under threat. Will the European Commission consider potential solutions from COCIR as a persuasive factor for change?
You may also be interested in...
Call For Risk-Based Extension For Legacy Products And No Sell-Off Deadline Under EU MDR
Might the EU decide to go the way of the IVD Regulation with the Medical Device Regulation and allow devices certified under the former regime to remain on the market into the mid 2020s and beyond?
Commission Offers Glimpse Of Actions To Speed Up MDR Compliance
With a sense of desperation building among stakeholders over the challenges in ensuring all products are compliant with the Medical Device Regulation in time, high-level solutions are being considered. But a further MDR delay is not an option.
European Regulatory Roundup, November 2022: EU MDR Situation Now Critical
Damage limitation action is expected imminently to try and stem the flow of medtech products being taken off the EU market. And it cannot come quickly enough as evidence continues to mount of the negative fall-out resulting from the way the EU’s new medical device regulations have been, and are being, implemented.